Using the hemoglobin switch for the treatment of sickle cell disease.
Jan
J
Cools
D000755:Anemia, Sickle Cell / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics*; D004268:DNA-Binding Proteins; D004195:Disease Models, Animal; D018390:Gene Targeting / Q000379:methods; D006454:Hemoglobins / Q000235:genetics*; D006801:Humans; D051379:Mice; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics*; D012097:Repressor Proteins; D016896:Treatment Outcome
C407733:Bcl11a protein, mouse; D002352:Carrier Proteins; D004268:DNA-Binding Proteins; D006454:Hemoglobins; D009687:Nuclear Proteins; D012097:Repressor Proteins